573 related articles for article (PubMed ID: 31942695)
1. In Silico design of AVP (4-5) peptide and synthesis, characterization and in vitro activity of chitosan nanoparticles.
Kecel-Gunduz S; Budama-Kilinc Y; Cakir-Koc R; Zorlu T; Bicak B; Kokcu Y; E Ozel A; Akyuz S
Daru; 2020 Jun; 28(1):139-157. PubMed ID: 31942695
[TBL] [Abstract][Full Text] [Related]
2. In silico Analysis of Sulpiride, Synthesis, Characterization and In vitro Studies of its Nanoparticle for the Treatment of Schizophrenia.
Kecel-Gunduz S; Budama-Kilinc Y; Cakir-Koc R; Zorlu T; Bicak B; Kokcu Y; Kaya Z; Ozel AE; Akyuz S
Curr Comput Aided Drug Des; 2020; 16(2):104-121. PubMed ID: 31244443
[TBL] [Abstract][Full Text] [Related]
3. Preparation of chitosan nanoparticles as Ginkgo Biloba extract carrier: In vitro neuroprotective effect on oxidative stress-induced human neuroblastoma cells (SH-SY5Y).
Karavelioglu Z; Cakir-Koc R
Int J Biol Macromol; 2021 Dec; 192():675-683. PubMed ID: 34655582
[TBL] [Abstract][Full Text] [Related]
4. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
5. Biopharmaceutical Potential of Selegiline Loaded Chitosan Nanoparticles in the Management of Parkinson's Disease.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Curr Drug Discov Technol; 2019; 16(4):417-425. PubMed ID: 29669501
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting.
Fazil M; Md S; Haque S; Kumar M; Baboota S; Sahni JK; Ali J
Eur J Pharm Sci; 2012 Aug; 47(1):6-15. PubMed ID: 22561106
[TBL] [Abstract][Full Text] [Related]
7. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
8. Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension.
Kecel-Gündüz S; Budama-Kilinc Y; Cakir Koc R; Kökcü Y; Bicak B; Aslan B; Özel AE
J Biomol Struct Dyn; 2018 Aug; 36(11):2893-2907. PubMed ID: 28835169
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, characterization, biological activities and molecular docking of Epilobium parviflorum aqueous extract loaded chitosan nanoparticles.
Egil AC; Ozdemir B; Gok B; Kecel-Gunduz S; Budama-Kilinc Y
Int J Biol Macromol; 2020 Oct; 161():947-957. PubMed ID: 32544580
[TBL] [Abstract][Full Text] [Related]
10. Exploring Endolysin-Loaded Alginate-Chitosan Nanoparticles as Future Remedy for Staphylococcal Infections.
Kaur J; Kour A; Panda JJ; Harjai K; Chhibber S
AAPS PharmSciTech; 2020 Aug; 21(6):233. PubMed ID: 32794119
[TBL] [Abstract][Full Text] [Related]
11. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
12. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats.
Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V
Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103
[TBL] [Abstract][Full Text] [Related]
13. Formulation and biopharmaceutical evaluation of risperidone-loaded chitosan nanoparticles for intranasal delivery.
Rukmangathen R; Yallamalli IM; Yalavarthi PR
Drug Dev Ind Pharm; 2019 Aug; 45(8):1342-1350. PubMed ID: 31094571
[No Abstract] [Full Text] [Related]
14. Antioxidant studies of chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung cancer cells.
Kumar SP; Birundha K; Kaveri K; Devi KT
Int J Biol Macromol; 2015; 78():87-95. PubMed ID: 25840152
[TBL] [Abstract][Full Text] [Related]
15. Controlled release of an endostatin peptide using chitosan nanoparticles.
Ebrahimi Samani S; Seraj Z; Naderimanesh H; Khajeh K; Esmaeili Rastaghi AR; Droudi T; Kolivand P; Kazemi H; Asghari SM
Chem Biol Drug Des; 2017 Sep; 90(3):417-424. PubMed ID: 28165672
[TBL] [Abstract][Full Text] [Related]
16. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study.
Hosseinzadeh H; Atyabi F; Dinarvand R; Ostad SN
Int J Nanomedicine; 2012; 7():1851-63. PubMed ID: 22605934
[TBL] [Abstract][Full Text] [Related]
17. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies.
Rastegari B; Karbalaei-Heidari HR; Zeinali S; Sheardown H
Colloids Surf B Biointerfaces; 2017 Oct; 158():589-601. PubMed ID: 28750341
[TBL] [Abstract][Full Text] [Related]
18. Synthesis characterisation and neuroprotectivity of
Ay HF; Yesilkir-Baydar S; Cakir-Koc R
J Microencapsul; 2023 Jan; 40(1):29-36. PubMed ID: 36632694
[TBL] [Abstract][Full Text] [Related]
19. Molecular docking of immunogenic peptide of Toxoplasma gondii and encapsulation with polymer as vaccine candidate.
Cakir-Koc R; Budama-Kilinc Y; Kokcu Y; Kecel-Gunduz S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):744-754. PubMed ID: 29741393
[TBL] [Abstract][Full Text] [Related]
20. Lomustine loaded chitosan nanoparticles: characterization and in-vitro cytotoxicity on human lung cancer cell line L132.
Mehrotra A; Nagarwal RC; Pandit JK
Chem Pharm Bull (Tokyo); 2011; 59(3):315-20. PubMed ID: 21372411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
